An overview from the United States.
作者信息
Besselaar G H, Tempero K F
出版信息
Clin Pharmacol Ther. 1974 Sep;16(3):620-4. doi: 10.1002/cpt1974163part2620.
PMID:4411989
Abstract
摘要
相似文献
1
An overview from the United States.
Clin Pharmacol Ther. 1974 Sep;16(3):620-4. doi: 10.1002/cpt1974163part2620.
2
HOW THE FOOD AND DRUG ADMINISTRATION EVALUATES NEW DRUG APPLICATIONS.美国食品药品监督管理局如何评估新药申请。
J New Drugs. 1964 Mar-Apr;4(2):63-74. doi: 10.1002/j.1552-4604.1964.tb00344.x.
3
Experimental designs for clinical trials of new animal drugs.新型动物用药物临床试验的实验设计
J Am Vet Med Assoc. 1972 Dec 1;161(11):1385-8.
4
Clinical pharmacology in Australia.
Clin Pharmacol Ther. 1974 Sep;16(3):545-53. doi: 10.1002/cpt1974163part2545.
5
Medicine and public affairs: Kennedy urges further pharmaceutical regulation.
N Engl J Med. 1974 May 23;290(21):1211-2. doi: 10.1056/NEJM197405232902130.
6
Constraints on innovation in drug development and use.
Psychopharmacol Bull. 1972 Apr;8(2):43-50.
7
WASHINGTON AND NEW DRUGS. NEW REGULATIONS REQUIRE FILING OF SAFETY AND EFFICACY DATA FOR NEW DRUGS INTRODUCED SINCE 1938.华盛顿与新药。新法规要求提交自1938年以来引入的新药的安全性和有效性数据。
J New Drugs. 1964 Mar-Apr;4(2):105-10. doi: 10.1002/j.1552-4604.1964.tb00351.x.
8
Failed and flawed drugs: a frozen resource.失败和有缺陷的药物：一种被冻结的资源。
Clin Pharmacol Ther. 1973 Sep-Oct;14(5):771-2. doi: 10.1002/cpt1973145771.
9
CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.美利坚合众国的药物毒性控制
Practitioner. 1965 Jan;194:16-21.
10
Medicines, governments and doctors.药品、政府和医生。
Drugs. 1972;3(5):305-13. doi: 10.2165/00003495-197203050-00001.
Zotero 插件